In this case, it is noteworthy that the GLP-1 agonist group had no worse visual outcomes compared to the acetazolamide monotherapy group across all primary outcome measures despite the increased risk due to their higher baseline BMI, the researchers wrote in their paper
Weight loss with the supplements is very slight, 1 to 4 pounds at best, White says
Thats an ad disguised as editorial content
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: a meta-analysis and meta-regression analysis
* Correspondence: Peijun Liu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Frequently Asked Questions What does the article say a remote provider reviews during the initial assessment
